All Sauce from Weekly Sauce:

For the estimated one-third of people with focal epilepsy who don’t respond well to initial medications, new research offers significant reason for optimism.  A study suggests that even those considered “treatment-resistant” may eventually see a substantial reduction in their seizures over time. Focal epilepsy, the most common form of the neurological disorder, occurs when nerve…  read on >  read on >

Encouraging parents to introduce peanuts to their infants early has led to a significant drop in new allergy diagnoses, according to researchers at the Children’s Hospital of Philadelphia. Their study —  published in the November issue of the journal Pediatrics — is the first large-scale analysis to show the real-world impact of the new feeding…  read on >  read on >

WEDNESDAY, Oct. 22, 2025  For women weighing whether to use estrogen to manage hot flashes, sleep issues and other bothersome symptoms as menopause approaches, it may make sense not to wait. New research shows that perimenopausal women who had used estrogen for at least 10 years before their periods stopped for good had 60% lower…  read on >  read on >

More than 91,000 pounds of frozen breakfast burritos and wraps distributed to food service institutions nationwide have been recalled due to possible Listeria contamination. The recall affects prepackaged frozen meals produced by M.C.I. Foods in California between Sept. 17 and Oct. 14, according to the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS).…  read on >  read on >

Menopause is typically associated with hot flashes, night sweats and memory lapses – but new research suggests GI problems might be an overlooked issue that also occur with this change of life. A striking 94% out of nearly 600 U.K. women 44 to 73 reported digestive problems, and of those 82% said their problems either…  read on >  read on >

Two widely available diabetes medications appear to safely improve brain health among people with early brain decline. The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health and blood flow to the brain, researchers recently reported in the journal Alzheimer’s & Dementia. “Our study suggests that targeting…  read on >  read on >

It’s one of the deadliest syndromes you’ve never heard of, but experts are hoping to change that. Nearly 9 of 10 Americans have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, even though about the same proportion are affected by it, according to a new survey by the American Heart Association (AHA). CKM syndrome represents a cluster…  read on >  read on >

The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of push to make in vitro fertilization (IVF) more affordable. The company’s drug GONAL-F, which helps stimulate ovulation, will soon be available at a discount through TrumpRx, a federal website expected to launch…  read on >  read on >